ATYR vs ZBRA · rev $190.0K vs P/E 28, rev $3.05B
aTyr Pharma, Inc. (ATYR) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
ATYR currently screens at market cap $471.7M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the ATYR and ZBRA stock pages for the full models.
Not investment advice.